Aurobindo Pharma Limited (AUROPHARMA.BO)
INR 1264.95
(1.37%)
INR 1264.95
(1.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 66.47 Billion INR | 25.75% |
| 2022 | 52.86 Billion INR | 61.22% |
| 2021 | 32.78 Billion INR | -38.59% |
| 2020 | 53.39 Billion INR | -15.27% |
| 2019 | 63.01 Billion INR | -9.55% |
| 2018 | 69.66 Billion INR | 46.06% |
| 2017 | 47.69 Billion INR | 41.79% |
| 2016 | 33.64 Billion INR | -33.27% |
| 2015 | 50.41 Billion INR | 14.68% |
| 2014 | 43.95 Billion INR | 16.62% |
| 2013 | 37.69 Billion INR | 9.71% |
| 2012 | 34.35 Billion INR | 10.97% |
| 2011 | 30.95 Billion INR | 28.24% |
| 2010 | 24.14 Billion INR | 12.05% |
| 2009 | 21.54 Billion INR | -8.1% |
| 2008 | 23.44 Billion INR | 22.19% |
| 2007 | 19.18 Billion INR | -7.96% |
| 2006 | 20.84 Billion INR | 51.2% |
| 2005 | 13.78 Billion INR | 33.34% |
| 2004 | 10.34 Billion INR | 25.63% |
| 2003 | 8.23 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 66.48 Billion INR | 0.0% |
| 2023 Q4 | 66.47 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 66.47 Billion INR | 25.75% |
| 2022 FY | 52.86 Billion INR | 61.22% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 45.01 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 52.86 Billion INR | 0.0% |
| 2021 Q4 | 32.78 Billion INR | 0.0% |
| 2021 FY | 32.78 Billion INR | -38.59% |
| 2021 Q2 | 47.66 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 53.39 Billion INR | 0.0% |
| 2020 FY | 53.39 Billion INR | -15.27% |
| 2020 Q2 | 52.11 Billion INR | 0.0% |
| 2019 Q2 | 60.76 Billion INR | 0.0% |
| 2019 FY | 63.01 Billion INR | -9.55% |
| 2019 Q4 | 63.01 Billion INR | 0.0% |
| 2018 FY | 69.66 Billion INR | 46.06% |
| 2018 Q2 | 55.44 Billion INR | 0.0% |
| 2018 Q4 | 69.66 Billion INR | 0.0% |
| 2017 Q4 | 47.69 Billion INR | 0.0% |
| 2017 FY | 47.69 Billion INR | 41.79% |
| 2017 Q2 | 48.08 Billion INR | 0.0% |
| 2016 FY | 33.64 Billion INR | -33.27% |
| 2016 Q2 | 39.32 Billion INR | 0.0% |
| 2016 Q4 | 33.64 Billion INR | 0.0% |
| 2015 Q2 | 42.19 Billion INR | 0.0% |
| 2015 Q4 | 50.41 Billion INR | 0.0% |
| 2015 FY | 50.41 Billion INR | 14.68% |
| 2014 Q2 | 31.32 Billion INR | 0.0% |
| 2014 Q4 | 43.95 Billion INR | 0.0% |
| 2014 FY | 43.95 Billion INR | 16.62% |
| 2013 Q2 | 35.05 Billion INR | 0.0% |
| 2013 Q4 | 37.69 Billion INR | 0.0% |
| 2013 FY | 37.69 Billion INR | 9.71% |
| 2012 Q4 | 34.35 Billion INR | 0.0% |
| 2012 FY | 34.35 Billion INR | 10.97% |
| 2011 Q4 | 30.95 Billion INR | 0.0% |
| 2011 FY | 30.95 Billion INR | 28.24% |
| 2010 FY | 24.14 Billion INR | 12.05% |
| 2009 FY | 21.54 Billion INR | -8.1% |
| 2008 FY | 23.44 Billion INR | 22.19% |
| 2007 FY | 19.18 Billion INR | -7.96% |
| 2006 FY | 20.84 Billion INR | 51.2% |
| 2005 FY | 13.78 Billion INR | 33.34% |
| 2004 FY | 10.34 Billion INR | 25.63% |
| 2003 FY | 8.23 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -18742.489% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -384534.033% |
| Sigachi Industries Limited | 1.43 Billion INR | -4547.012% |
| Bal Pharma Limited | 1.39 Billion INR | -4660.262% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -39893.924% |
| Medico Remedies Limited | 80.5 Million INR | -82475.152% |
| Lasa Supergenerics Limited | 220.76 Million INR | -30012.202% |
| Venus Remedies Limited | 413.3 Million INR | -15984.273% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -10771.022% |
| Alpa Laboratories Limited | 52.46 Million INR | -126605.994% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -945.987% |
| Shilpa Medicare Limited | 9.37 Billion INR | -609.165% |
| Aarti Drugs Limited | 5.64 Billion INR | -1078.094% |
| Lupin Limited | 29.21 Billion INR | -127.521% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -726.614% |
| Windlas Biotech Limited | 36.41 Million INR | -182477.039% |
| Suven Life Sciences Limited | 7.09 Million INR | -936581.696% |
| Eris Lifesciences Limited | 27.81 Billion INR | -139.014% |
| Valiant Laboratories Limited | 767.08 Million INR | -8566.104% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -1660.216% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -557.205% |
| Ipca Laboratories Limited | 14.38 Billion INR | -362.167% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -6558.277% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | -103.064% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -1897.339% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | -3108.743% |
| Laurus Labs Limited | 25.77 Billion INR | -157.92% |
| Piramal Pharma Limited | 47.1 Billion INR | -41.134% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -9070.84% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | -65.282% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -1195.43% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -440.049% |
| Unichem Laboratories Limited | 2.47 Billion INR | -2585.757% |
| Sequent Scientific Limited | 4.87 Billion INR | -1263.077% |
| Novartis India Limited | 69.7 Million INR | -95274.892% |
| Wanbury Limited | 1.16 Billion INR | -5606.875% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -10127.69% |
| Wockhardt Limited | 23.56 Billion INR | -182.157% |
| Themis Medicare Limited | 957.92 Million INR | -6839.636% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -74249.961% |
| Jubilant Pharmova Limited | 36.64 Billion INR | -81.431% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -38666.212% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | -232.049% |
| Divi's Laboratories Limited | 30 Million INR | -221487.667% |
| NATCO Pharma Limited | 3.71 Billion INR | -1690.849% |
| Gufic Biosciences Limited | 3.32 Billion INR | -1896.791% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -20191.911% |
| Ind-Swift Limited | 10.13 Billion INR | -555.588% |
| Procter & Gamble Health Limited | 95.6 Million INR | -69435.879% |
| FDC Limited | 205.18 Million INR | -32298.226% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -3336.72% |
| Granules India Limited | 13.15 Billion INR | -405.499% |
| Medicamen Biotech Limited | 308.17 Million INR | -21471.168% |
| Alkem Laboratories Limited | 14.18 Billion INR | -368.668% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -144470.267% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -1514511.529% |
| Brooks Laboratories Limited | 56.41 Million INR | -117726.087% |
| Megasoft Limited | 1.47 Billion INR | -4420.752% |
| ZIM Laboratories Limited | 1.08 Billion INR | -6008.584% |
| Strides Pharma Science Limited | 25.16 Billion INR | -164.123% |
| Neuland Laboratories Limited | 953.89 Million INR | -6868.925% |
| Morepen Laboratories Limited | 289.99 Million INR | -22823.494% |
| Hikal Limited | 8.17 Billion INR | -713.086% |
| Indoco Remedies Limited | 6.71 Billion INR | -889.29% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -2230.457% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -20905.893% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -6649.377% |
| Hester Biosciences Limited | 2.44 Billion INR | -2620.224% |